Werner syndrome: A changing pattern of clinical manifestations: In Japan (1917~2008)

BioScience Trends

Volumn 7, Issue 1, 2013, Pages 13-22

  Goto, Makoto ^a,b   Ishikawa, Yuichi ^c   Sugimoto, Masanobu ^d   Furuichi, Yasuhiro ^d  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

^d GeneCare Research Institute Co Ltd   (Japan)

Author keywords

Aging; Cancer prone syndrome; Helicase; Inflammation; Longevity; Premature aging; Werner syndrome

Indexed keywords

EXODEOXYRIBONUCLEASE; RECQ HELICASE; WRN PROTEIN, HUMAN;

ADULT; FEMALE; GENETICS; HUMAN; JAPAN; MALE; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PREMATURE AGING; REVIEW; WERNER SYNDROME;

ADULT; AGING, PREMATURE; EXODEOXYRIBONUCLEASES; FEMALE; HUMANS; JAPAN; MALE; MUTATION; RECQ HELICASES; WERNER SYNDROME;

EID: 84875947376     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2013.v7.1.13     Document Type: Review

References (76)

1. Goto M, Rubenstein M, Weber J, Woods K, Drayna D. Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature. 1992; 355:735-738.
2. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD. Positional cloning of the Werner syndrome gene. Science. 1996; 272:258-262.
3. Goto M, Imamura O, Kuromitsu J, Matsumoto T, Yamabe Y, Tokutake Y, Suzuki N, Mason B, Drayna D, Sugawara M, Sugimoto M, Furuichi Y. Analysis of helicase gene mutations in Japanese Werner's syndrome patients. Hum Genet. 1997; 99: 191-193.
4. Goto M. Hierarchical deterioration of body systems in Werner's syndrome: Implications for normal ageing. Mech Age Dev. 1997; 98:239-254.
5. Epstein CJ, Martin GM, Schultz AG, Motulsky AG. Werner's syndrome. A review of its symptomatology, natural history, pathologic features, genetics and relationship to natural aging process. Medicine (Baltimore). 1966; 45:177-221.
6. Martin GM. Genetic syndrome in man with potential relevance to the pathobiology of aging. Birth Defects Orig Article Ser. 1978; 14:5-39.
7. Martin GM. Genetics and aging: the Werner syndrome as a segmental progeroid syndrome. Adv Exp Med Biol. 1985; 190:161-170.
8. van Brabant AJ, Stan R, Ellis NA. DNA helicases, genomic instability, and human genetic diseases. Annu Rev Genomics Hum Genet. 2000; 1:409-459.
9. Stano NM, Jeong Y-J, Donmez I, Tummalapalli P, Levin MK, Patel SS. DNA synthesis provides the driving force to accelerate DNA unwinding by helicase. Nature. 2005; 435:370-373.
10. Matsumoto T, Shimamoto A, Goto M, Furuichi Y. Impaired nuclear localization of defective DNA helicases in Werner's syndrome. Nat Genet. 1997; 16:335-336.
11. Werner O. On cataract in conjunction with scleroderma. Doctoral dissertation. Kiel University. Schmidt and Klaunig, Kiel, Germany, 1904.
12. Goto M, Matsuura M. Secular trends towards delayed onsets of pathologies and prolonged longevities in Japanese patients with Werner syndrome. BioSci Trends. 2008; 2:81-87.
13. Faragher R, Goto M. An international effort to cure premature ageing. BioSci Trends. 2007; 1:66-67.
14. Goto M, Tanimoto K, Horiuchi Y, Sasazuki T. Family analysis of Werner's syndrome: A survey of 42 Japanese families with a review of the literature. Clin Genet. 1981; 19:8-15.
15. Goto M. Clinical characteristics of Werner syndrome and other premature aging syndromes: Pattern of aging in progeroid syndromes. In: From premature gray hair to helicase-Werner syndrome:Implications for aging and cancer. Gann Monograph on Cancer Research No.49. (Goto M, Miller RW, eds.). Karger, Tokyo, Japan, 2001; pp.27-39.
16. Matsumoto T, Tsuchihashi Z, Ito C, Fujita K, Goto M, Furuichi Y. Genetic diagnosis of Werner's syndrome, a premature aging disease, by mutant allele specific amplification (MASA) and oligomer ligation assay (OLA). J Anti-Aging Med. 1998; 1:131-140.
17. Matsumoto T, Imamura O, Yamabe Y, Kuromutsu J, Tokutake Y, Shimamoto A, Suzuki N, Satoh Mi, Kitao S, Ichikawa K, Kataoka H, Sugawara K, Thomas W, Mason B, Tsuchihashi Z, Drayna D, Sugawara M, Sugimoto M, Furuichi Y, Goto M. Mutation and haplotype analyses of the Werner's syndrome gene based on its genomic structure:genetic epidemiology in the Japanese population. Hum Genet. 1997; 100:123-130.
18. Rothmund A. On cataract in conjunction with a characteristic skin degeneration. Graefes Arch Ophthal. 1868; 14:159-182.
19. Thomson MS. An hitherto undescribed familial disease. Br J Dermatol. 1923; 35:455-462.
20. Thannhauser SJ. Werner's syndrome (progeria of the adult) and Rothmund's syndrome; 2 types of closely related heredofamilial atrophic dermatoses; critical study with 5 new cases. Ann Intern Med. 1945; 23:559-626.
21. Kitao S, Shimamoto A, Goto M, Miller RW, Smithson WA, Lindor NM, Furuichi Y. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat Genet. 1999; 22:82-84.
22. Ishida R. A case of cataract associated with scleroderma. Jpn J Ophthalmol. 1917; 21:1025-1032. (in Japanese).
23. Goto M, Miller RW, Ishikawa Y, Sugano H. Excess of rare cancers in Werner syndrome (Adult progeria). Cancer Epidemiol Biomarkers Prev. 1996; 5:239-246.
24. Oppenheimer BS, Kugel VH. Werner's syndrome: a heredofamilial disorder with scleroderma, bilateral juvenile cataract, precocious graying of hair and endocrine stigmatization. Trans Assoc Am Physicians. 1934; 49:358-370.
25. Oppenheimer BS, Kugel VH. Werner's syndrome, report of the first necropsy and findings in a new case. Am J Med Sci. 1941; 202:629-642.
26. Agatson SA, Gartner G. Precocious cataracts and scleroderma (Rothmund's syndrome: Werner's syndrome). Arch Ophthalmol. 1939; 21:492-496.
27. Hamada Y. Werner's syndrome: Report of a case with post-mortem findings. Jpn J Clin Dermatol Urol. 1966; 20:61-65. (in Japanese).
28. Koga M. Werner's syndrome associated with malignant melanoma. Jpn J Clin Dermatol Urol. 1968; 22:1160-1161. (in Japanese).
29. Goto M, Kindynis P, Resnick D, Sartoris DJ. Osteosclerosis of the phalanges in Werner syndrome. Radiology. 1989; 172:841-843.
30. Shiraki M, Aoki C, Goto M. Bone and calcium metabolism in Werner's syndrome. Endocr J. 1998; 45:505-512.
31. Endo K, Minamisaki T, yamashita H, Ozaki M, Yoshioka T, Yamashita H, Teshima R. A case of Werner syndrome associated with recurrent fibrosarcoma. J Jpn Orthop Assoc. 2003; 77:S787.
32. Goto M, Horiuchi Y, Tanimoto K, Ishii T, Nakashima H. Werner's syndrome: Analysis of 15 cases with a review of the Japanese literature. J Am Geriatr Soc. 1978; 26:341-347.
33. Yokote K, Honjo S, Kobayashi K, Kawamura H, Mori S, Saito Y. Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone. J Am Geriatr Soc. 2004; 52:1582-1583.
34. Martin GM, Gartler SM, Epstein CJ, Motulsky AJ. Diminished lifespan of cultured cells in Werner's syndrome. Fed Proc. 1965; 24:678.
35. Hatamochi A. Dermatological features and collagen metabolism in Werner syndrome. In: From premature gray hair to helicase-Werner syndrome:Implications for aging and cancer. Gann monograph on Cancer research No.49. (Goto M, Miller RW. Eds.). Karger, Tokyo, Japan. 2001; pp. 51-59.
36. Goto M, Yamabe Y, Shiratori M, Okada M, Kawabe K, Matsumoto T, Sugimoto M, Furuichi Y. Immunological diagnosis of Werner syndrome by down-regulated and truncated gene products. Hum Genet. 1999; 105:301-307.
37. Goto M, Kato Y. Hypercoagulable state indicates an additional risk factor for atherosclerosis in Werner's syndrome. Thromb Haemost. 1995; 73:576-578.
38. Yokote K, Hara K, Mori S, Kadowaki T, Saito Y, Goto M. Dysadiponectinemia in Werner syndrome and its recovery by treatment with pioglitazone. Diabetes Care. 2004; 27:2562-2563.
39. Hashizume H, Sato K, Takagi H, Kanda D, Kashihara T, Kiso S, Mori M. Werner syndrome as a possible cause of non-alcoholic steatohepatitis. J Clin Pathol. 2009; 62:1043-1045.
40. Goto M, Takeuchi F, Tanimoto K, Miyamoto T. Clinical, demographic, and genetic aspects of the Werner syndrome in Japan. In: Werner's syndrome and human aging. Advances in experimental medicine and biology. Vol. 190. (Salk D, Fujiwara Y, Martin GM. eds.). Plenum Press, New York, USA, 1985; pp. 245-261.
41. Takeuchi F, Kamatani N, Goto M, Matsuta K, Nishida Y, Nishioka K, Mikanagi K, Miyamoto T. Gout-like arthritis in patients with Werner's syndrome. Jpn J Rheumatol. 1987; 1:215-220.
42. Libby P. Inflammation in athrosclerosis. Nature. 2002; 420:868-874.
43. Mori S, Yokote K, Kondo Y, Murano S, Saito Y. Mild atherosclerosis in an autopsy case of Werner syndrome. Aging Dis. 1999; 12:742-745. (in Japanese).
44. Tokunaga M, Futami T, Wakamatsu E, Endo M, Yoshizawa Z. Werner's syndrome as "hyaluronuria". Clin Chim Acta. 1975; 62:89-92.
45. Goto M, Murata K. Urinary excretion of macromolecular acidic glycosaminoglycans in Werner's syndrome. Clin Chim Acta. 1978; 85:101-106.
46. Maeda H, Fujita H, Sakura Y, Miyazaki K, Goto M. A competitive enzyme-linked immunosorbent assay like method for the detection of urinary hyaluronan. Biosci Biotechnol Biochem. 1999; 63:892-895.
47. Tanabe M, Goto M. Elevation of serum hyaluronan level in Werner's syndrome. Gerontology. 2001; 47:77-81.
48. Laurent TC. Serum hyaluronan as a disease marker. Ann Med. 1996; 28:241-253.
49. Lindquvist U. The diurnal variation of serum hyaluronan in health and disease. Scand J Clin Lab Invest. 1988; 48:765-770.
50. Manicourt DH, Poilvache P, Nzeusseu A, van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ. Serum levels of hyaluronan, antigenic keratin sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest. Arthritis Rheum. 1999; 42:1861-1869.
51. Emlen W, Niebur J, F lander s G, Rutledge J. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. J Rheumatol. 1996; 23:974-978.
52. Guechot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol. 1994; 20:388-393.
53. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panougia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Age Dev. 2007; 128:92-105.
54. Goto M. Inflammaging (inflammation+aging): A driving force for human aging based on an evolutionarily antagonistic pleiotrpy theory? BioSci Trends. 2008; 2:218-230.
55. Goto M, Nishioka K. Age-and sex-related changes of the lymphocyte subsets in healthy individuals: an analysis by two-dimensional flow cytometry. J Gerontol. 1989; 44:M51-56.
56. Goto M, Horiuchi Y, Okumura K, Tada T, Kawata M, Ohmori K. Immunological abnormalities of aging: an analysis of T lymphocyte subpopulations of Werner's syndrome. J Clin Invest. 1979; 64:695-699.
57. Goto M, Tanimoto K, Horiuchi Y, Kuwata T. Reduced natural killer cell activity of lumphocytes from patients with Werner's syndrome and recovery of its activity by purified human leukocyte interferon. Scand J Immunol. 1982; 15:389-397.
58. Goto M, Tanimoto K, Aotsuka A, Okawa M, Yokohari R. Age-related changes in auto- and natural antibody in the Werner's syndrome. Am J Med. 1982; 72:607-614.
59. Goto M, Tanimoto K, Miyamoto T. Immunological aspects of the Werner's syndrome. In: Werner's syndrome and human aging. Advances in experimental medicine and biology. Vol. 190. (Salk D, Fujiwara Y, Martin GM. eds.). Plenum Press, New York, USA, 1985; pp. 263-284.
60. Goto M. Immunosenescent features of human segmental progeroid syndrome: Werner's syndrome. Aging Immunol Infect Dis. 1992; 3:203-215.
61. Goto M, Sugimoto K, Hayashi S, Ogino T, Sugimoto M, Furuichi Y, Matsuura M, Ishikawa Y, Iwaki-Egawa S, Watanabe Y. Aging-associated inflammation in healthy Japanese individuals and the patients with Werner syndrome. Exp Gerontol. 2012; 47:936-939.
62. Sumi SM. Neuropathology of Werner syndrome. In: Werner's syndrome and human aging. Advances in experimental medicine and biology. Vol. 190. (Salk D, Fujiwara Y, Martin GM. eds.). Plenum Press, New York, USA, 1985; pp. 215-218.
63. Kuroda Y. Nervous system disorders in Werner syndrome. In: From premature gray hair to helicase- Werner syndrome:Implications for aging and cancer. Gann Monograph on Cancer Research No.49. (Goto M, Miller RW, eds.). Karger, Tokyo, Japan, 2001; pp. 69-75.
64. Kakigi R, Endo C, Negishi R, Kohno H, Kuroda Y. Accelerated aging of the brain in Werner's syndrome. Neurology. 1992; 42:922-924.
65. Kawamura H, Tamura K, Yokote K, Mori S, Murano S, Saito K, Okada S, Kodama k, Satomi D. A case of Werner syndrome associated with Binswanger encephalopathy. Jpn J Geriatr. 1998; 35:578-579. (in Japanese).
66. Amagasa M, Yuda F. A case of Werner syndrome associated with multiple meningioma. Yamagata Saiseikann Ishi. 2005; 30:83-88. (in Japanese).
67. Mori H, Tomiyama T, Maeda N, Ozawa K, Wakasa K. Lack of amyloid plaque formation in the central nervous system of a patient with Werner syndrome. Neuropathology. 2003; 23:51-56.
68. Maekawa A, Fukudome K, Masuda Y, Sugawara H, Kubo T. A consideration on the background and pathogenesis of mood disorder in Werner syndrome. Shinshini. 2005; 45:236. (in Japanese).
69. Ishikawa Y, Sugano H, Matsumoto T, Furuichi Y, Miller RW, Goto M. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer. 1999; 85:1345-1352.
70. Iguchi H, Takayama M, Kusuki M, Sunami K, Nakamura A, Yamane H, Yamashita Y, Ohira M, Hirakawa K. A possible case of Werner syndrome presenting with multiple cancers. Acta Otolaryngol (Suppl). 2004; 554:67-70.
71. Satoh M, Matsumoto T, Imai M, Sugimoto M, Tsugane S, Furuichi Y, Goto M. Prevalence of Werner syndrome gene mutations in the Japanese population: A genetic epidemiological study. In: From premature gray hair to helicase-Werner syndrome: Implications for aging and cancer. Gann Monograph on Cancer Research No.49. (Goto M, Miller RW. eds.). Karger, Tokyo, Japan, 2001; pp. 19-25.
72. Satoh M, Imai M, Sugimoto M, Goto M, Furuichi Y. Prevalence of Werner's syndrome heterozygotes in Japan. Lancet. 1999; 353:1766.
73. Meguro S, Atsumi Y, Matsuoka K, Ishikawa Y, Sugimoto M, Goto M. Werner syndrome in a Korean man. Diabetes Diab Care. 2002; 25:1483-1484.
74. Martin GM, Sprague CR, Epstein CJ. Replicative life-span of cultivated human cells. Lab Invest. 1970; 23:86-92.
75. Ishikawa N, Nakamura K, Izumiyama-Shimomura N, Aida J, Ishii A, Goto M, Ishikawa Y, Asaka R, Matuura M, Hatamochi A, Kuroiwa M, Takubo K. Accelerated in vivo epidermal telomere loss in Werner syndrome. Aging. 2011; 3:417-429.
76. Labbe A, Lafleur VN, Patten DA, Robitaille GA, Garand C, Lamalice L, Lebel M, Richard DE. The Werner syndrome gene product (WRN): a repressor of hypoxia-inducible factor-1 activity. Exp Cell Res. 2012; 318:1620-1632.